Monitor for regulatory approvals (antitrust, CFIUS) and the tender offer expiration on December 3, 2026. The deal is fully financed with cash on hand and has majority shareholder support, reducing execution risk.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 13 $15.73entry
- T+1 · 20h ago −0.32%α +1.59% · $15.68
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
Executive Summary
EnerSys filed Amendment No. 1 to its Schedule TO, adding exhibits from its Q2 FY2027 earnings call and presentation that discuss the proposed $16.00 per share cash acquisition of Ultralife. The filing confirms the tender offer expires December 3, 2026, and EnerSys expects to close the deal in Q1 2027, funded with cash on hand, with $15M-$20M in annual cost synergies targeted within 18 months of closing.
Key Financial Metrics
Key Facts
- EnerSys is acquiring Ultralife for $16.00 per share in cash, enterprise value ~$320M.
- The tender offer expires at 5:00 PM New York City time on December 3, 2026.
- EnerSys expects to close in Q1 2027, subject to regulatory approvals and a majority-of-shares tender condition.
- EnerSys expects $15M-$20M in annual run-rate cost synergies within 18 months of closing.
- Stockholders representing ~40.3% of Ultralife shares have already agreed to tender via a Tender and Support Agreement.
- The transaction is expected to be accretive to EnerSys adjusted EPS within ~18 months of closing.
- EnerSys plans to fund the acquisition with cash on hand.
- The valuation implies an 8.3x multiple of Ultralife's synergy-adjusted trailing 12-month adjusted EBITDA.
Financial Impact
Enterprise value of approximately $320 million, or $16.00 per share in cash.
Risk Factors
- Regulatory approvals (antitrust, CFIUS) may delay or block the transaction.
- The tender offer requires a majority of outstanding shares to be tendered; failure to meet this condition could terminate the deal.
- Integration risks and the ability to achieve the projected $15M-$20M in cost synergies.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC TO-T/A Filing (Primary) | 0001193125-26-459401 |
| Document: d169477dsctota.htm | 0001193125-26-459401 |
| Document: d169477dex99a5b.htm | 0001193125-26-459401 |
| Document: 0001193125-26-459401-index-headers.html | 0001193125-26-459401 |
| Document: 0001193125-26-459401-index.html | 0001193125-26-459401 |
| Document: 0001193125-26-459401.txt | 0001193125-26-459401 |
Track record
21 reports on ULBI
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +125.22% at T+60 after the Aug 7, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 13, 20263d ago SC TO-T/A Mixed 7/10 Viewing Entry $15.73 Now $15.68 −0.32% settles Feb 11
- Nov 12, 20264d ago SC 13D/A Neutral 2/10 Entry $15.73 Now $15.68 −0.32% settles Feb 11
- Nov 9, 20267d ago 8-K Neutral 5/10 Entry $15.69 Now $15.68 −0.06% settles Feb 5
- Nov 5, 202611d ago Press Release Neutral 5/10 Entry $15.66 Now $15.68 +0.13% settles Feb 4
- Oct 29, 202618d ago SC 13D/A Neutral 6/10 Entry $15.62 Now $15.68 +0.38% settles Jan 28
- Oct 28, 202619d ago SC 14D-9 Bullish 7/10 Entry $15.62 Now $15.68 +0.38% settles Jan 27
- Oct 28, 202619d ago 8-K Bullish 8/10 Entry $15.61 Now $15.68 +0.45% settles Jan 26
- Oct 28, 202619d ago SC TO-T Bullish 7/10 Entry $15.61 Now $15.68 +0.45% settles Jan 26
- Oct 27, 202620d ago SC TO-C Bullish 6/10 Entry $15.61 Now $15.68 +0.45% settles Jan 26
- Oct 27, 202620d ago Press Release Bullish 8/10 Entry $15.61 Now $15.68 +0.45% settles Jan 26
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers